SCHEMBL2855696

SCHEMBL2855696

COC(=O)c1ccc(C=C(C=O)c2ccc(F)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
MAPK1 P28482 2/20 0.53
MAPT P10636 2/20 0.53
HTT P42858 1/20 0.53
ATM Q13315 1/20 0.51
TDP1 Q9NUW8 1/20 0.47
NQO2 P16083 2/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
POLB P06746 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
KDM4E B2RXH2 1/20 0.46
PTGS1 P23219 1/20 0.45
LMNA P02545 1/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2855693 1.00 ALDH1A1 (0.56) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL8059859 1.00 ALDH1A1 (0.56) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL30873483 0.85 NQO2 (0.52) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL3743501 0.83 CA12 (0.51) KMT2AMEN1MAPTNQO2POLB
SCHEMBL3743503 0.83 CA12 (0.51) KMT2AMEN1MAPTNQO2POLB
SCHEMBL13044967 0.83 CA12 (0.51) KMT2AMEN1MAPTNQO2POLB
SCHEMBL12295084 0.80 PTPN1 (0.63) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL28025111 0.80 PTPN1 (0.63) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL12973297 0.80 PTPN1 (0.63) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL15437059 0.80 PTPN1 (0.63) ALDH1A1NPC1RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450525-B2 Histone deacetylase inhibitors ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2013-05-28 US disclosed
US-20100291003-A1 HISTONE DEACETYLASE INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2010-11-18 US disclosed
EP-2209765-A2 HISTONE DEACETYLASE INHIBITORS Orchid Research Laboratories Limited (IN) 2010-07-28 EP disclosed
WO-2009053808-A2 HISTONE DEACETYLASE INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100291003-A1 HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HDAC5 ALDH1A1 473/4885NPC1 1846/4885RAB9A 3320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.